{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:36:08Z","timestamp":1787020568283,"version":"build-2736575974"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-025-00832-5","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:00:49Z","timestamp":1762344049000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Nitrofurantoin resistance mechanisms in uropathogenic Escherichia coli isolates from Iran"],"prefix":"10.1186","volume":"24","author":[{"given":"Shayesteh","family":"Novin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Elham","family":"Rezatofighi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Roayaei Ardakani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"key":"832_CR1","doi-asserted-by":"publisher","unstructured":"Subashchandrabose S, Mobley HLT. Virulence and fitness determinants of uropathogenic Escherichia coli. Microbiol Spectr. 2015;3(4). https:\/\/doi.org\/10.1128\/microbiolspec.UTI-0015-2012.","DOI":"10.1128\/microbiolspec.UTI-0015-2012"},{"issue":"2","key":"832_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.4103\/0255-0857.96657","volume":"30","author":"J Agarwal","year":"2012","unstructured":"Agarwal J, Srivastava S, Singh M. Pathogenomics of uropathogenic Escherichia coli. Indian J Med Microbiol. 2012;30(2):141\u20139.","journal-title":"Indian J Med Microbiol"},{"issue":"3","key":"832_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1080\/00325481.2019.1680052","volume":"132","author":"MS Bader","year":"2020","unstructured":"Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132(3):234\u201350.","journal-title":"Postgrad Med"},{"key":"832_CR4","unstructured":"Squadrito FJ, del Portal D. Nitrofurantoin. StatPearls. Treasure Island (FL). StatPearls Publishing; 2024."},{"issue":"3","key":"832_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1093\/jac\/dkn222","volume":"62","author":"L Sandegren","year":"2008","unstructured":"Sandegren L, Lindqvist A, Kahlmeter G, et al. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli. J Antimicrob Chemother. 2008;62(3):495\u2013503.","journal-title":"J Antimicrob Chemother"},{"issue":"21","key":"832_CR6","doi-asserted-by":"publisher","first-page":"5529","DOI":"10.1128\/JB.180.21.5529-5539.1998","volume":"180","author":"J Whiteway","year":"1998","unstructured":"Whiteway J, Koziarz P, Veall J, et al. Oxygen-Insensitive nitroreductases: analysis of the roles of NfsA and NfsB in development of resistance to 5-Nitrofuran derivatives in Escherichia coli. J Bacteriol. 1998;180(21):5529\u201339.","journal-title":"J Bacteriol"},{"key":"832_CR7","doi-asserted-by":"publisher","first-page":"3757","DOI":"10.1007\/s11033-022-07215-5","volume":"49","author":"N Jomehzadeh","year":"2022","unstructured":"Jomehzadeh N, Saki M, Ahmadi K, et al. The prevalence of plasmid-mediated quinolone resistance genes among Escherichia coli strains isolated from urinary tract infections in Southwest Iran. Mol Biol Rep. 2022;49:3757\u201363.","journal-title":"Mol Biol Rep"},{"issue":"6","key":"832_CR8","doi-asserted-by":"publisher","first-page":"390","DOI":"10.24171\/j.phrp.2021.0272","volume":"12","author":"N Jomehzadeh","year":"2021","unstructured":"Jomehzadeh N, Ahmadi Kh, Rahmani Z. Prevalence of plasmid-mediated AmpC \u03b2-lactamases among uropathogenic Escherichia coli isolates in Southwestern Iran. Osong Public Health Res Perspect. 2021;12(6):390\u20135.","journal-title":"Osong Public Health Res Perspect"},{"issue":"12","key":"832_CR9","doi-asserted-by":"publisher","first-page":"7225","DOI":"10.1128\/AAC.03952-14","volume":"58","author":"J Vervoort","year":"2014","unstructured":"Vervoort J, Xavier BB, Stewardson A, et al. An in vitro deletion in RibE encoding lumazine synthase contributes to Nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother. 2014;58(12):7225\u201333.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"832_CR10","doi-asserted-by":"publisher","first-page":"FSO293","DOI":"10.4155\/fsoa-2017-0156","volume":"4","author":"JO Sekyere","year":"2018","unstructured":"Sekyere JO. Genomic insights into Nitrofurantoin resistance mechanisms and epidemiology in clinical Enterobacteriaceae. Future Sci OA. 2018;4(5):FSO293.","journal-title":"Future Sci OA"},{"key":"832_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12941-021-00457-4","volume":"20","author":"F Zangane Matin","year":"2021","unstructured":"Zangane Matin F, Rezatofighi SE, Roayaei Ardakani M, et al. Virulence characterization and clonal analysis of uropathogenic Escherichia coli metallo-beta-lactamase-producing isolates. Ann Clin Microbiol Antimicrob. 2021;20:1\u201313.","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"832_CR12","unstructured":"CLSI. Performance Standards for Antimicrobial Susceptibility Testing. 33rd ed. CLSI supplement M100. Clinical and Laboratory Standards Institute; 2023."},{"key":"832_CR13","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1128\/JCM.02069-13","volume":"52","author":"F Toval","year":"2014","unstructured":"Toval F, K\u00f6hler CD, Vogel U, et al. Characterization of Escherichia coli isolates from hospital inpatients or outpatients with urinary tract infection. J Clin Microbiol. 2014;52:407\u201318.","journal-title":"J Clin Microbiol"},{"key":"832_CR14","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/j.1600-0463.2007.apm_630.x","volume":"115","author":"S Stepanovi\u0107","year":"2007","unstructured":"Stepanovi\u0107 S, Vukovi\u0107 D, Hola V, et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci. APMIS. 2007;115:891\u20139.","journal-title":"APMIS"},{"key":"832_CR15","doi-asserted-by":"publisher","first-page":"e01660","DOI":"10.1128\/AEM.01660-17","volume":"83","author":"J Schiebel","year":"2017","unstructured":"Schiebel J, B\u00f6hm A, Nitschke J, et al. Genotypic and phenotypic characteristics associated with biofilm formation by human clinical Escherichia coli isolates of different pathotypes. Appl Environ Microbiol. 2017;83:e01660\u201317.","journal-title":"Appl Environ Microbiol"},{"key":"832_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3390\/microorganisms9040693","volume":"9","author":"JAS Nascimento","year":"2021","unstructured":"Nascimento JAS, Santos FF, Valiatti TB, et al. Frequency and diversity of hybrid Escherichia coli strains isolated from urinary tract infections. Microorganisms. 2021;9:693.","journal-title":"Microorganisms"},{"key":"832_CR17","doi-asserted-by":"publisher","first-page":"3361","DOI":"10.1007\/s00284-020-02173-2","volume":"77","author":"R Baldiris\u2013Avila","year":"2020","unstructured":"Baldiris\u2013Avila R, Montes\u2013Robledo A, Buelvas\u2013Montes Y. Phylogenetic Classification, Biofilm\u2013Forming Capacity, virulence Factors, and antimicrobial resistance in uropathogenic Escherichia coli (UPEC). Curr Microbiol. 2020;77:3361\u201370.","journal-title":"Curr Microbiol"},{"key":"832_CR18","doi-asserted-by":"publisher","first-page":"4602","DOI":"10.1128\/AAC.00725-13","volume":"57","author":"F Perez","year":"2013","unstructured":"Perez F, Rudin SD, Marshall SH, et al. OqxAB, a quinolone and olaquindox efflux pump, is widely distributed among multidrug-resistant Klebsiella pneumoniae isolates of human origin. Antimicrob Agents Chemother. 2013;57:4602\u20133.","journal-title":"Antimicrob Agents Chemother"},{"key":"832_CR19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1128\/AAC.02156-15","volume":"60","author":"PL Ho","year":"2016","unstructured":"Ho PL, Ng KY, Lo WU, et al. Plasmid-mediated OqxAB is an important mechanism for Nitrofurantoin resistance in Escherichia coli. Antimicrob Agents Chemother. 2016;60:537\u201343.","journal-title":"Antimicrob Agents Chemother"},{"key":"832_CR20","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1093\/bioinformatics\/btv195","volume":"31","author":"Y Choi","year":"2015","unstructured":"Choi Y, Chan AP. PROVEAN web server: a tool to predict the functional effect of amino acid substitutions and indels. Bioinformatics. 2015;31:2745\u20137.","journal-title":"Bioinformatics"},{"key":"832_CR21","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/1758-2229.12019","volume":"5","author":"O Clermont","year":"2013","unstructured":"Clermont O, Christenson JK, Denamur E, et al. The Clermont Escherichia coli phylo-typing method revisited: improvement of specificity and detection of new phylo-groups. Environ Microbiol Rep. 2013;5:58\u201365.","journal-title":"Environ Microbiol Rep"},{"issue":"6","key":"832_CR22","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1128\/AEM.02171-06","volume":"73","author":"TJ Johnson","year":"2007","unstructured":"Johnson TJ, Wannemuehler YM, Johnson SJ, et al. Plasmid replicon typing of commensal and pathogenic Escherichia coli isolates. J Appl Environ Microbiol. 2007;73(6):1976\u201383.","journal-title":"J Appl Environ Microbiol"},{"key":"832_CR23","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1086\/315217","volume":"181","author":"JR Johnson","year":"2000","unstructured":"Johnson JR, Stell AL. Extended virulence genotypes of Escherichia coli strains from patients with Urosepsis in relation to phylogeny and host compromise. J Infect Dis. 2000;181:261\u201372.","journal-title":"J Infect Dis"},{"issue":"9","key":"832_CR24","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1111\/j.1469-0691.2006.01461.x","volume":"12","author":"M Sabat\u00e9","year":"2006","unstructured":"Sabat\u00e9 M, Moreno E, P\u00e9rez T, et al. Pathogenicity Island markers in commensal and uropathogenic Escherichia coli isolates. Clin Microbiol Infect. 2006;12(9):880\u20136.","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"832_CR25","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3390\/antibiotics3010039","volume":"3","author":"MJ Munoz-Davila","year":"2014","unstructured":"Munoz-Davila MJ. Role of old antibiotics in the era of antibiotic resistance. Highlighted Nitrofurantoin for the treatment of lower urinary tract infections. Antibiot (Basel). 2014;3(1):39\u201348.","journal-title":"Antibiot (Basel)"},{"key":"832_CR26","doi-asserted-by":"publisher","first-page":"1148603","DOI":"10.3389\/fcimb.2023.1148603","volume":"13","author":"M Mahdizade Ari","year":"2023","unstructured":"Mahdizade Ari M, Dashtbin S, Ghasemi F, et al. Nitrofurantoin: properties and potential in treatment of urinary tract infection: a narrative review. Front Cell Infect Microbiol. 2023;13:1148603.","journal-title":"Front Cell Infect Microbiol"},{"key":"832_CR27","unstructured":"Mirzarazi M, Rezatofighi SE, Pourmahdi M. M, Antibiotic resistance of isolated gram negative bacteria from urinary tract infections (UTIs) in Isfahan. Jundishapur J Microbiol 20136(8):1E."},{"key":"832_CR28","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1186\/s12879-018-3467-0","volume":"18","author":"Y Malekzadegan","year":"2018","unstructured":"Malekzadegan Y, Khashei R, Sedigh Ebrahim-Saraie H, et al. Distribution of virulence genes and their association with antimicrobial resistance among uropathogenic Escherichia coli isolates from Iranian patients. BMC Infect Dis. 2018;18:572.","journal-title":"BMC Infect Dis"},{"issue":"5","key":"832_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.24171\/j.phrp.2018.9.5.02","volume":"9","author":"MR Asadi Karam","year":"2018","unstructured":"Asadi Karam MR, Habibi M, Bouzari S. Relationships between virulence factors and antimicrobial resistance among Escherichia coli isolated from urinary tract infections and commensal isolates in Tehran, Iran. Osong Public Health Res Perspect. 2018;9(5):217\u201324.","journal-title":"Osong Public Health Res Perspect"},{"issue":"3","key":"832_CR30","first-page":"508","volume":"53","author":"A Fakhri-Demeshghieh","year":"2024","unstructured":"Fakhri-Demeshghieh A, Shokri A, Bokaie S. Antibiotic resistance of uropathogenic Escherichia coli (UPEC) among Iranian pediatrics: A systematic review and Meta-Analysis. Iran J Public Health. 2024;53(3):508\u201323.","journal-title":"Iran J Public Health"},{"issue":"2","key":"832_CR31","doi-asserted-by":"publisher","first-page":"000321","DOI":"10.1099\/acmi.0.000321","volume":"4","author":"S Mohapatra","year":"2022","unstructured":"Mohapatra S, Panigrahy R, Tak V, et al. Prevalence and resistance pattern of uropathogens from community settings of different regions: an experience from India. Access Microbiol. 2022;4(2):000321.","journal-title":"Access Microbiol"},{"key":"832_CR32","first-page":"121","volume":"34","author":"B Khamari","year":"2025","unstructured":"Khamari B, Bulagonda EP. Unlocking nitrofurantoin: Understanding molecular mechanisms of action and resistance in enterobacterales. Med Princ Pract. 2025;34:121\u201337.","journal-title":"Med Princ Pract"},{"issue":"12","key":"832_CR33","doi-asserted-by":"publisher","first-page":"3259","DOI":"10.1093\/jac\/dku282","volume":"69","author":"GV Sanchez","year":"2014","unstructured":"Sanchez GV, Baird AMG, Karlowsky JA, et al. Nitrofurantoin retains antimicrobial activity against multidrug-resistant urinary Escherichia coli from US outpatients. J Antimicrob Chemother. 2014;69(12):3259\u201362.","journal-title":"J Antimicrob Chemother"},{"key":"832_CR34","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jgar.2018.11.004","volume":"17","author":"S Ny","year":"2019","unstructured":"Ny S, Edquist P, Dumpis U, et al. Antimicrobial resistance of Escherichia coli isolates from outpatient urinary tract infections in women in six European countries including Russia. J Glob Antimicrob Resist. 2019;17:25\u201334.","journal-title":"J Glob Antimicrob Resist"},{"key":"832_CR35","volume-title":"Antibiotic resistance & patient safety portal: multidrug-resistant Escherichia coli profile","author":"Centers for Disease Control and Prevention","year":"2023","unstructured":"Centers for Disease Control and Prevention. Antibiotic resistance & patient safety portal: multidrug-resistant Escherichia coli profile. Atlanta (GA): CDC; 2023. https:\/\/arpsp.cdc.gov\/profile\/antibiotic-resistance\/mdr-ecoli."},{"key":"832_CR36","doi-asserted-by":"crossref","unstructured":"Larkin C, Valappil SP, Palanisamy N. Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis. J Antimicrob Chemother. 2025:dkaf305.","DOI":"10.1093\/jac\/dkaf305"},{"key":"832_CR37","doi-asserted-by":"publisher","first-page":"103889","DOI":"10.1016\/j.resmic.2021.103889","volume":"173","author":"B Khamari","year":"2022","unstructured":"Khamari B, Adak S, Chanakya PP, et al. Prediction of Nitrofurantoin resistance among Enterobacteriaceae and mutational landscape of in vitro selected resistant Escherichia coli. Microbiol Res. 2022;173:103889.","journal-title":"Microbiol Res"},{"key":"832_CR38","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.jgar.2019.10.002","volume":"21","author":"F Mottaghizadeha","year":"2020","unstructured":"Mottaghizadeha F, Mohajjel Shojaa H, Haeilia M, et al. Molecular epidemiology and Nitrofurantoin resistance determinants of Nitrofurantoin-non-susceptible Escherichia coli isolated from urinary tract infections. J Glob Antimicrob Resist. 2020;21:335\u20139.","journal-title":"J Glob Antimicrob Resist"},{"issue":"7","key":"832_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/aac.00242-24","volume":"68","author":"P Dulyayangkul","year":"2024","unstructured":"Dulyayangkul P, Sealey JE, Lee WWY, et al. Improving Nitrofurantoin resistance prediction in Escherichia coli from whole-genome sequence by integrating NfsA\/B enzyme assays. Antimicrob Agents Chemother. 2024;68(7):1\u201314.","journal-title":"Antimicrob Agents Chemother"},{"key":"832_CR40","doi-asserted-by":"publisher","first-page":"534","DOI":"10.3390\/antibiotics9090534","volume":"9","author":"A Sorlozano-Puerto","year":"2020","unstructured":"Sorlozano-Puerto A, Lopez-Machado I, Albertuz-Crespo M, et al. Characterization of fosfomycin and Nitrofurantoin resistance mechanisms in Escherichia coli isolated in clinical urine samples. Antibiotics. 2020;9:534.","journal-title":"Antibiotics"},{"key":"832_CR41","first-page":"000702","volume":"7","author":"ME WanY","year":"2021","unstructured":"WanY ME, Leung RCY, et al. Alterations in chromosomal genes nfsA, nfsB, and RibE are associated with Nitrofurantoin resistance in Escherichia coli from the united Kingdom. Microb Genom. 2021;7:000702.","journal-title":"Microb Genom"},{"issue":"2","key":"832_CR42","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.ijantimicag.2018.04.021","volume":"52","author":"X Zhang","year":"2018","unstructured":"Zhang X, Zhang Y, Wang F, et al. Unraveling the mechanisms of Nitrofurantoin resistance and epidemiological characteristics among Escherichia coli clinical isolates. Int J Antimicrob Agents. 2018;52(2):226\u201332.","journal-title":"Int J Antimicrob Agents"},{"key":"832_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/jac\/dkac398","volume":"78","author":"M Vall\u00e9e","year":"2023","unstructured":"Vall\u00e9e M, Harding C, Hall J, et al. Exploring the in situ evolution of Nitrofurantoin resistance in clinically derived uropathogenic Escherichia coli isolates. J Antimicrob Chemother. 2023;78:373\u20139.","journal-title":"J Antimicrob Chemother"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-025-00832-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-025-00832-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T12:00:51Z","timestamp":1762344051000},"score":1,"resource":{"primary":{"URL":"https:\/\/ann-clinmicrob.biomedcentral.com\/articles\/10.1186\/s12941-025-00832-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,5]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["832"],"URL":"https:\/\/doi.org\/10.1186\/s12941-025-00832-5","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,5]]},"assertion":[{"value":"30 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by Ethics Committee of Shahid Chamran University of Ahvaz (IR.SCU.REC.1403.031). Before collecting information, participants or parents (for children cases) were asked to read, accept and sign an informed consent form.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"62"}}